About
Valitor is a startup biotechnology company currently operating in the East Bay Innovation Center in West Berkeley. We are developing a new generation of biotechnology drugs that act precisely within a targeted disease tissue. With our platform technology, we have developed novel methods of modifying therapeutic proteins to achieve substantial control over their pharmacokinetics, target specificity and bioactivity. We are developing drug products to improve patient outcomes and reduce the clinical burden required for effective treatment of our target diseases, with our lead product to improve the treatment of diseases in ophthalmology.